Legal notice

Site publisher

MedQara
Project published by Fidèle M'PO
Biomedical Engineering student (engineering cycle)
ISIFC - University of Franche-Comté
Besançon, France

Email: contact@veillemedqara.fr

Publication director

Fidèle M'PO

Hosting

Web application

Render Services Inc.
525 Brannan Street, San Francisco, CA 94107, USA
Hosting region: Frankfurt (Germany, EU)
Site: render.com

Database

Supabase Inc.
970 Toa Payoh North, #07-04, Singapore 318992
Hosting region: Europe West (Frankfurt, Germany, EU)
Site: supabase.com

CDN, security and analytics

Cloudflare Inc.
101 Townsend St, San Francisco, CA 94107, USA
GDPR compliant (DPF certified).

Intellectual property

All content on the MedQara site (code, design, logos, editorial text) is protected by copyright. Any reproduction, representation, modification, publication or adaptation, in whole or in part, is prohibited without prior written authorization.

Regulatory content aggregated from official sources (ANSM, HAS, EMA, FDA, MDCG, EUR-Lex, Légifrance, ISO, etc.) remains the property of its respective authors and is used for informational and monitoring purposes, with systematic citation of the source.

Limitation of liability

MedQara is a regulatory monitoring support tool. AI-generated summaries and analyses are guidance tools and do not replace direct consultation of official texts or the opinion of a qualified QA/RA expert.

We make every effort to ensure the accuracy of the information relayed, but cannot guarantee its completeness or perfect timeliness. The user remains solely responsible for verifying the information used in their regulatory decisions.

Personal data

The processing of your personal data is detailed in our Privacy policy.

Cookies

MedQara only uses essential technical cookies for the operation of the service (authentication session). No third-party marketing tracking cookies are used. Analytics is anonymous and cookieless (Cloudflare Web Analytics).

Applicable law

This site is governed by French law. Any dispute relating to its use falls under the exclusive jurisdiction of the French courts.